PSYENCE BIOMEDICAL LTD. - COM SHS (PBM)

CUSIP: 74449F407

Q1 2026 13F Holders as of 31 Mar 2026

Share change
+89
SEC-reported price per share
$3.12
Number of holders
2
Value change
+$218
Number of buys
1

Security key

74449F407

Report period

Q1 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of PBM - PSYENCE BIOMEDICAL LTD. - COM SHS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Psyence Labs Ltd
Disclosed value leader
Psyence Labs Ltd
Comparable rows
9/15
Latest evidence
25 Feb 2026
13D/G 13F Lead comparable stake: 30% 6 rows are not safely comparable across share classes. 13D/G row: Psyence Labs Ltd Showing 1-6 of 15 holder rows.

Quick read

Psyence Labs Ltd leads the comparable SEC ownership view at 30%.

9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Psyence Labs Ltd's linked filing trail.
Comparable ownership Top 5
Psyence Labs Ltd 30%
Hudson Bay Capital Management LP 5%
Kaos Capital Ltd 4.9%
Weiner Jeffrey David 2.6%
AdvisorShares Trust 0.79%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Psyence Labs Ltd
13D/G
30%
$825,234
1,146,159 shares
$0 25 Feb 2026
Hudson Bay Capital Management LP
13D/G
5%
$133,150
237,768 shares
-$79,650 31 Mar 2025
Kaos Capital Ltd
13D/G
4.9%
$236,098
313,876 shares
$0 08 Jan 2026
Weiner Jeffrey David
13D/G
2.6%
$43,020
59,750 shares
+$5,688 25 Feb 2026
AdvisorShares Trust
13D/G
0.79%
$15,077
26,924 shares
$0 31 Dec 2024
Virtu Financial LLC
13F
Company
13F
1.6%
$28,000
37,042 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
151,339
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
1
Q1 2026 holders
2
Holder diff
1
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .